Literature DB >> 25824952

Selective inhibition of miR-21 by phage display screened peptide.

Debojit Bose1, Smita Nahar2, Manish Kumar Rai2, Arjun Ray2, Kausik Chakraborty2, Souvik Maiti3.   

Abstract

miRNAs are nodal regulators of gene expression and deregulation of miRNAs is causally associated with different diseases, including cancer. Modulation of miRNA expression is thus of therapeutic importance. Small molecules are currently being explored for their potential to downregulate miRNAs. Peptides have shown to have better potency and selectivity toward their targets but their potential in targeting and modulating miRNAs remain unexplored. Herein, using phage display we found a very selective peptide against pre-miR-21. Interestingly, the peptide has the potential to downregulate miR-21, by binding to pre-miR-21 and hindering Dicer processing. It is selective towards miR-21 inside the cell. By antagonising miR-21 function, the peptide is able to increase the expression of its target proteins and thereby increase apoptosis and suppress cell proliferation, invasion and migration. This peptide can further be explored for its anti-cancer activity in vivo and may be even extended to clinical studies.
© The Author(s) 2015. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25824952      PMCID: PMC4417150          DOI: 10.1093/nar/gkv185

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  54 in total

Review 1.  MicroRNAs in embryonic stem cell function and fate.

Authors:  Gustavo Tiscornia; Juan Carlos Izpisúa Belmonte
Journal:  Genes Dev       Date:  2010-12-15       Impact factor: 11.361

Review 2.  MicroRNAs in vascular and metabolic disease.

Authors:  Anna Zampetaki; Manuel Mayr
Journal:  Circ Res       Date:  2012-02-03       Impact factor: 17.367

3.  The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation.

Authors:  Hsin-Sheng Yang; Aaron P Jansen; Anton A Komar; Xiaojing Zheng; William C Merrick; Sylvain Costes; Stephen J Lockett; Nahum Sonenberg; Nancy H Colburn
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

Review 4.  MicroRNAs in stress signaling and human disease.

Authors:  Joshua T Mendell; Eric N Olson
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

5.  miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma.

Authors:  Qin Zhu; Zhiming Wang; Yu Hu; Jindong Li; Xinying Li; Ledu Zhou; Yun Huang
Journal:  Oncol Rep       Date:  2012-02-09       Impact factor: 3.906

6.  Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells.

Authors:  Lisa B Frankel; Nanna R Christoffersen; Anders Jacobsen; Morten Lindow; Anders Krogh; Anders H Lund
Journal:  J Biol Chem       Date:  2007-11-08       Impact factor: 5.157

7.  MicroRNA-21 targets tumor suppressor genes in invasion and metastasis.

Authors:  Shuomin Zhu; Hailong Wu; Fangting Wu; Daotai Nie; Shijie Sheng; Yin-Yuan Mo
Journal:  Cell Res       Date:  2008-03       Impact factor: 25.617

8.  MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer.

Authors:  Peter Olson; Jun Lu; Hao Zhang; Anny Shai; Matthew G Chun; Yucheng Wang; Steven K Libutti; Eric K Nakakura; Todd R Golub; Douglas Hanahan
Journal:  Genes Dev       Date:  2009-09-15       Impact factor: 11.361

9.  A mammalian microRNA expression atlas based on small RNA library sequencing.

Authors:  Pablo Landgraf; Mirabela Rusu; Robert Sheridan; Alain Sewer; Nicola Iovino; Alexei Aravin; Sébastien Pfeffer; Amanda Rice; Alice O Kamphorst; Markus Landthaler; Carolina Lin; Nicholas D Socci; Leandro Hermida; Valerio Fulci; Sabina Chiaretti; Robin Foà; Julia Schliwka; Uta Fuchs; Astrid Novosel; Roman-Ulrich Müller; Bernhard Schermer; Ute Bissels; Jason Inman; Quang Phan; Minchen Chien; David B Weir; Ruchi Choksi; Gabriella De Vita; Daniela Frezzetti; Hans-Ingo Trompeter; Veit Hornung; Grace Teng; Gunther Hartmann; Miklos Palkovits; Roberto Di Lauro; Peter Wernet; Giuseppe Macino; Charles E Rogler; James W Nagle; Jingyue Ju; F Nina Papavasiliou; Thomas Benzing; Peter Lichter; Wayne Tam; Michael J Brownstein; Andreas Bosio; Arndt Borkhardt; James J Russo; Chris Sander; Mihaela Zavolan; Thomas Tuschl
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

10.  PEP-FOLD: an updated de novo structure prediction server for both linear and disulfide bonded cyclic peptides.

Authors:  Pierre Thévenet; Yimin Shen; Julien Maupetit; Frédéric Guyon; Philippe Derreumaux; Pierre Tufféry
Journal:  Nucleic Acids Res       Date:  2012-05-11       Impact factor: 16.971

View more
  17 in total

1.  Discovery of Nucleic Acid Binding Molecules from Combinatorial Biohybrid Nucleobase Peptide Libraries.

Authors:  Sebastian Pomplun; Zachary P Gates; Genwei Zhang; Anthony J Quartararo; Bradley L Pentelute
Journal:  J Am Chem Soc       Date:  2020-11-09       Impact factor: 15.419

2.  Tetracyclines as Inhibitors of Pre-microRNA Maturation: A Disconnection between RNA Binding and Inhibition.

Authors:  Amanda L Garner; Daniel A Lorenz; Jorge Sandoval; Erin E Gallagher; Samuel A Kerk; Tanpreet Kaur; Arya Menon
Journal:  ACS Med Chem Lett       Date:  2019-04-22       Impact factor: 4.345

3.  A Macrocyclic Peptide Ligand Binds the Oncogenic MicroRNA-21 Precursor and Suppresses Dicer Processing.

Authors:  Matthew D Shortridge; Matthew J Walker; Tom Pavelitz; Yu Chen; Wen Yang; Gabriele Varani
Journal:  ACS Chem Biol       Date:  2017-05-02       Impact factor: 5.100

Review 4.  Small molecules targeting microRNA for cancer therapy: Promises and obstacles.

Authors:  Di Wen; Michael Danquah; Amit Kumar Chaudhary; Ram I Mahato
Journal:  J Control Release       Date:  2015-08-06       Impact factor: 9.776

Review 5.  Tumor-targeting peptides from combinatorial libraries.

Authors:  Ruiwu Liu; Xiaocen Li; Wenwu Xiao; Kit S Lam
Journal:  Adv Drug Deliv Rev       Date:  2016-05-19       Impact factor: 15.470

6.  Constrained peptides mimic a viral suppressor of RNA silencing.

Authors:  Arne Kuepper; Niall M McLoughlin; Saskia Neubacher; Alejandro Yeste-Vázquez; Estel Collado Camps; Chandran Nithin; Sunandan Mukherjee; Lucas Bethge; Janusz M Bujnicki; Roland Brock; Stefan Heinrichs; Tom N Grossmann
Journal:  Nucleic Acids Res       Date:  2021-12-16       Impact factor: 16.971

7.  Reprogramming of Protein-Targeted Small-Molecule Medicines to RNA by Ribonuclease Recruitment.

Authors:  Peiyuan Zhang; Xiaohui Liu; Daniel Abegg; Toru Tanaka; Yuquan Tong; Raphael I Benhamou; Jared Baisden; Gogce Crynen; Samantha M Meyer; Michael D Cameron; Arnab K Chatterjee; Alexander Adibekian; Jessica L Childs-Disney; Matthew D Disney
Journal:  J Am Chem Soc       Date:  2021-08-13       Impact factor: 16.383

8.  Advancement and applications of peptide phage display technology in biomedical science.

Authors:  Chien-Hsun Wu; I-Ju Liu; Ruei-Min Lu; Han-Chung Wu
Journal:  J Biomed Sci       Date:  2016-01-19       Impact factor: 8.410

Review 9.  miRNAs Signature in Head and Neck Squamous Cell Carcinoma Metastasis: A Literature Review.

Authors:  Soussan Irani
Journal:  J Dent (Shiraz)       Date:  2016-06

Review 10.  Noncoding RNA therapeutics - challenges and potential solutions.

Authors:  Melanie Winkle; Sherien M El-Daly; Muller Fabbri; George A Calin
Journal:  Nat Rev Drug Discov       Date:  2021-06-18       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.